Clinical Report: Analyzing Candidemia in Critically Ill Patients

Background

Candidemia is a serious infection associated with high morbidity and mortality, particularly in critically ill patients. Understanding the different clinical phenotypes can aid in better risk stratification and management of these patients. However, the integration of machine learning in identifying these phenotypes must be critically evaluated for clinical applicability.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Three distinct phenotypes of candidemia were identified: immunosuppressed hematological patients, deteriorating cirrhotic patients, and patients with catheter-related infections.
• Phenotypes 1 and 2 had approximately 70% mortality rates, while Phenotype 3 had a 50% mortality rate.
• Concerns were raised about the methodological weaknesses, including feature selection bias and algorithmic tautology.
• The inclusion of the Simplified Acute Physiology Score II (SAPS II) in the clustering algorithm was criticized for potentially skewing results.
• Future models should exclude broad clinical scores linked to mortality to achieve genuine precision medicine.

Clinical Implications

Healthcare professionals should be cautious when interpreting machine learning-derived phenotypes in candidemia. The findings emphasize the need for rigorous methodological standards in studies utilizing advanced computational techniques.

Conclusion

The study presents important insights into candidemia phenotypes but also highlights significant methodological concerns that could impact clinical utility.

Related Resources & Content

1. Reizine et al., Critical Care, 2023 -- Analyzing Candidemia in Critically Ill Patients
2. Seymour et al., JAMA Network Open, 2023 -- Multicenter Validation of Clinical Sepsis Phenotypes
3. Intensive Care Medicine, 2014 -- Prognostic Indicators and Trends in Candidemia Epidemiology Among Critically Ill Patients
4. Critical Care, 2025 -- Identification of Clinical Subphenotypes in Sepsis Through Mixed Data Analysis
5. International Journal of Infectious Diseases — TIME TO POSITIVITY AS A DIAGNOSTIC TOOL FOR CATHETER-RELATED CANDIDEMIA: A SPECIES-SPECIFIC ANALYSIS
6. Global guideline for the diagnosis and management of candidiasis
7. IDSA 2016 Clinical Practice Guideline Update for the Management of Candidiasis
8. Surviving Sepsis Campaign Adult Guidelines
9. untitled
10. Screening for Ocular Candidiasis Among Patients With Candidemia: Is It Time to Change Practice?  | Clinical Infectious Diseases | Oxford Academic
11. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial - PubMed
12. Managing Candida auris fungemias: the results of a prospective and international study | Antimicrobial Agents and Chemotherapy
13. Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States - Volume 32, Number 5—May 2026 - Emerging Infectious Diseases journal - CDC
14. Clinical Overview of Candida auris | Candida auris (C. auris) | CDC
15. Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement | Journal of Anesthesia, Analgesia and Critical Care | Springer Nature Link
16. Decoding candidemia in critically ill patients: unsupervised clustering identifies three unique phenotypes - PubMed
17. Defining the threshold duration of candidemia associated with poor outcomes: Redefining persistent candidemia - ScienceDirect
18. Two-step deep-learning candidemia prediction model using two large time-sequence electronic health datasets - PMC